Regulation of Peroxisome Proliferator-Activated Receptors

Vitamins and Hormones

Volumn 54, Issue C, 1998, Pages 121-166

  Sørensen, Hilde Nebb ^a   Treuter, Eckardt ^b   Gustafsson, Jan Ake ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR;

GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR CLONING; REVIEW; SIGNAL TRANSDUCTION; TRANSACTIVATION;

CLONING, MOLECULAR; GENE EXPRESSION REGULATION; NUCLEAR PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 0031601757     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(08)60924-3     Document Type: Article

References (164)

1. Albrektson, T., Treuter, E., Schrøder, L., Jacobsen, D., Valentin, M., Göttlicher, M., Kristiansen, K., Gustafsson, J.-A., and Knudsen, J. (1997). Binding of a photo reactive fatty acid to the rat peroxisome proliferator activated receptor α. Manuscript in preparation.
2. Aldridge T.C., Tugwood J.D., and Green S. Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription. Biochem. J. 306 (1995) 473-479
3. Alvares K., Carrillo A., Yuan P.M., Kawano H., Morimito R.I., and Reddy J.K. Identification of cytosolic peroxisome proliferator binding protein as a member of the heat shock protein hsp70 family. Proc. Natl. Acad. Sci. USA 87 (1990) 5293-5297
4. Amero S.A., Kretsinger R.H., Moncrief N.D., Yamamoto K.R., and Pearson W.R. The origin of nuclear receptor proteins-A single precursor distinct from other transcription factors. Mol. Endocrinol. 6 (1992) 3-7
5. Auwerx J. Regulation of gene expression by fatty acids and fibric acid derivatives: An integrative role for peroxisome proliferator activated receptors. The Belgian Endocrine Society Lecture. Hormone Res. 38 (1992) 269-277
6. Bagchi M.K., Tsai S.Y., Weigel N.L., Tsai M.-J., and O'Malley B.W. Regulation of in vitro transcription by progesterone receptor. J. Biol. Chem. 266 (1990) 5129-5134
7. Bannister A.J., and Kouzarides T. The CBP co-activator is a histone acetyl-transferase. Nature (London 384 (1996) 641-643
8. Bardot O., Aldridge T.C., Latruffe N., and Green S. PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene. Biochem. Biophys. Res. Commun. 192 (1993) 37-45
9. Beato M. Transcriptional control by nuclear receptors. FASEB J. 5 (1991) 2044-2051
10. Berger J., Bailey P., Biswas C., Cullinan C.A., Doebber T.W., Hayes N.S., Saperstein R., Smith R.G., and Leibowitz M.D. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-γ: Binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology 137 (1996) 4189-4194
11. Bocos C., Göttlicher M., Gearing K., Banner C., Enmark E., Teboul M., Crickmore A., and Gustafsson J.-A. Fatty acid activation of peroxisome proliferator-activated receptor (PPAR. J. Steroid Biochem. Mol. Biol. 53 (1995) 467-473
12. Bogazzi F., Hudson L.D., and Nikodem V.M. A novel heterodimerization partner for thyroid hormone receptor. Peroxosome proliferator-activated receptor. J. Biol. Chem. 269 (1994) 11683-11686
13. Braissant O., Foufelle F., Scotto C., Dauca M., and Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-α, -β, and -γ in the adult rat. Endocrinology 137 (1996) 354-366
14. Brun R.P., Tontonoz P., Forman B.M., Ellis R., Chen J., Evans R.M., and Spiegelman B.M. Differential activation of adipogenesis by multiple PPAR isoforms. Genes Dev. 10 (1996) 974-984
15. Castelein H., Gulick T., Declercq P.E., Mannaerts G.P., Moore D., and Baes M.I. The peroxisome proliferator-activated receptor regulates malic enzyme gene expression. J. Biol. Chem. 269 (1994) 2754-2758
16. Cavailles V., Dauvois S., Danielian P.S., and Parker M.G. Interaction of proteins with transcriptionally active estrogen receptors. Proc. Natl. Acad. Sci. USA 91 (1994) 10009-10013
17. Cavailles V., Dauvois S., L'Horset F., Lopez G., Hoare S., Kushner P.J., and Parker M.G. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J 14 (1995) 3741-3751
18. Chakravarti D., Lamorte V.J., Nelson M.C., Nakajima T., Schulman I.G., Juguilon H., Montminy M., and Evans R.M. Role of CBP/P300 in nuclear receptor signaling. Nature (London 383 (1996) 99-103
19. Chawla A., Schwartz E.J., Dimaculangan D.D., and Lazae M.A. Peroxisome proliferator-activated receptor (PPAR) γ: Adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 135 (1994) 798-800
20. Chen F., Law S.W., and O'Malley B.W. Identification of two mPPAR related receptors and evidence for the existence of five subfamily members. Biochim. Biophys. Res. Commun. 196 (1993) 671-677
21. Chen J.D., and Evans R.M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature (London 377 (1995) 454-457
22. Christel A., Pognonec P., Saladin R., Auwerx J., and Boulukos K.E. cDNA cloning and characterization of the transcriptional activities of the hamster peroxisome proliferator-activated receptor haPPARγ. Gene 162 (1995) 297-302
23. Chu R., Madison L.D., Lin Y., Kopp P., Rao M.S., Jameson J.L., and Reddy J.K. Thyroid hormone (T3) inhibits ciprofibrate-induced transcription of genes encoding β-oxidation enzymes: Cross-talk between peroxisome proliferator and T3 signaling pathways. Proc. Natl. Acad. Sci. USA 92 (1995) 11593-11597
24. Chu R.Y., Lin Y.L., Rao M.S., and Reddy J.K. Cloning and identification of rat deoxyuridine triphosphatase as an inhibitor of peroxisome proliferator-activated receptor alpha. J. Biol. Chem. 271 (1996) 27670-27676
25. Devchand P.R., Keller H., Peters L.M., Vazques M., Gonzales F.J., and Wahli W. The PPARα-leukotriene B4 pathway to inflammation control. Nature 384 (1996) 39-43
26. Dowell P., Peterson V.J., Zabriskie T.M., and Leid M. Ligand-induced peroxisome proliferator-activated receptor alpha conformational change. J. Biol. Chem. 272 (1997) 2013-2020
27. Dreyer D., Krey G., Keller H., Givel F., Helftenbein G., and Wahli W. Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68 (1992) 879-887
28. Dreyer D., Keller H., Mahfoudi A., Laudet V., Krey G., and Wahli W. Positive regulation of the peroxisomal β-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors (PPAR. Biol. Cell 77 (1993) 67-76
29. Elbrecht A., Chen Y., Cullinan C.A., Hayes N., Leibowitz M.D., Moller D.E., and Berger J. Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors γ1 and γ2. Biochim. Biophys. Res. Commun. 224 (1996) 431-437
30. Elcombe C.R., and Mitchell A.M. Peroxisomal proliferation due to di(2-ethyl-hexyl) phatalate (DEHP): Species differences and possible mechanisms. Environ. Health Perspect. 70 (1986) 211-219
31. Elliston J.F., Fawell S.E., Klein-Hitpass L., Tsai S.Y., Tsai M.-J., Parker M.G., and O'Malley B.W. Mechanisms of estrogen receptor-dependent transcription in a cell-free system. Mol. Cell. Biol. 10 (1990) 6607-6612
32. Evans R.M. The steroid and thyroid hormone receptor superfamily: Transcriptional regulators of development and physiology. Science 240 (1988) 889-895
33. Forman B.M., and Samuels H.H. Interaction among a subfamily of nuclear hormone receptors: The regulatory zipper model. Mol. Endocrinol. 4 (1990) 1293-1301
34. 2 is a ligand for the adipocyte determination factor PPARγ. Cell 83 (1995) 803-812
35. Foxworthy P.S., and Eacho P.I. Inhibition of hepatic fatty acid oxidation at carnitine palmitoyltransferase I by the peroxisome proliferator 2-hydroxy-3-propyl-4-[6-(tetrazol-5-yl) hexloxy]acetophenone. Biochem. J. 252 (1988) 409-414
36. Fukushima M. Biological activities and mechanisms of action of PGJ2 and related compounds: An update. Prostaglandins Leukot. Essent. Fatty Acids 47 (1992) 1-12
37. Gearing K.L., Göttlicher M., Teboul M., Widmark E., and Gustafsson J.-A. Interaction of the peroxisome-proliferator-activated receptor and retinoid receptor. Proc. Natl. Acad. Sci. USA 90 (1993) 1440-1444
38. Gearing K.L., Crickmore A., and Gustafsson J.-A. Structure of the mouse peroxisome proliferator activated receptor α gene. Biochim. Biophys. Res. Commun. 199 (1994) 255-263
39. Glass C.K. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocrine Rev. 15 (1994) 391-407
40. Göttlicher M., Widmark E., Li Q., and Gustafsson J.-A. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA 89 (1992) 4653-4657
41. Göttlicher M., Demoz A., Svensson D., Toilet P., Berge R.K., and Gustafsson J.-A. Structural and metabolic requirements for activators of peroxisome proliferator activated receptor. Biochem. Pharmacol. 46 (1993) 2177-2184
42. Green H., and Kehinde O. Sublinesa of mouse 3T3 cells that accumulate lipid. Cell 3 (1974) 113-116
43. Green H., and Kehinde O. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 5 (1975) 19-27
44. Green S. PPAR: A mediator of peroxisome proliferator action. Mutat. Res. 333 (1995) 101-109
45. Green S., and Wahli W. Peroxisome proliferator-activated receptors: Finding the orphan a home. Mol. Cell. Endocrinol. 100 (1994) 149-153
46. Green S., Tugwood J.D., and Issemann I. The molecular mechanism of peroxisome proliferator action: A model for species differences and mechanistic risk assessment. Toxocol. Lett. 6465 (1992) 131-139
47. Greene M.E., Blumberg B., McBride W., Yi H.F., Kronquist K., Kwan K., Hsieh L., Grenne G., and Nimer S.D. Isolation of the human peroxisome proliferator activated receptor gamma cDNA: Expression in hematopoietic cells and chromosomal mapping. Gene Expression 4 (1995) 281-299
48. Gronemeyer H. Control of transcriptional activation by steroid hormone receptors. FASEB J. 6 (1992) 2524-2529
49. Guardiola-Diaz, H., Albrektsen, T., Alexson, S. E. H., and Gustafsson, J.-Å. (1997). Unpublished observations.
50. Gulick T., Cresci S., Caira T., Moore D., and Kelly D. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc. Natl. Acad. Sci. USA 91 (1994) 11012-11016
51. Gustafsson J.-A. Receptor-mediated toxicity. Toxicol. Lett. 8283 (1995) 465-470
52. Halachmi S., Marden E., Martin G., MacKay H., Abbondanza C., and Brown M. Estrogen receptor-associated proteins: Possible mediators of hormone-induced transcription. Science 264 (1994) 1455-1458
53. Hales C.N., Luzio J.P., and Siddle K. Hormonal control of adipose-tissue lipolysis. Biochem. Soc. Symp. 43 (1978) 97-135
54. ω). Identification of a new cytochrome P-450 gene family. J. Biol. Chem. 262 (1987) 801-810
55. Hertz R., Bishara-Shieban J., and Bar-Tana J. Mode of action of peroxisome proliferators as hypolipidemic drugs, suppression of apolipoprotein C-III. J. Biol. Chem. 270 (1995) 13470-13475
56. Hertz R., Berman I., Keppler D., and Bar-Tana J. Activation of gene transcription by prostacyclin analogues is mediated by the peroxisome-proliferator-activated receptor (PPAR. Eur. J. Biochem. 235 (1996) 242-247
57. Hörlein A.J., Näär A.M., Heinzel T., Torchia J., Gloss B., Kurokawa R., Ryan A., Kamei M., Söderström Y., Glass C.K., and Rosenfeld M.G. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature (London 377 (1995) 397-404
58. Horwitz K.B., Jackson T.A., Rain D.L., Richer J.K., Takimoto G.S., and Tung L. Nuclear receptor coactivators and corepressors. Mol. Endocrinol. 10 (1996) 1167-1177
59. Hu E.D., Kim J.B., Sarraf P., and Spiegelman B.M. Inhibition of adipogenesis through map kinase-mediated phosphorylation of PPAR-gamma. Science 274 (1996) 2100-2103
60. Huang Q., Alvares K., Chu R., Bradfield C.A., and Reddy J.K. Association of peroxisome proliferator-activated receptor and Hsp72. J. Biol. Chem. 269 (1994) 8493-8497
61. Hunter J., Kassam A., Winrow C.J., Rachubinski R.A., and Capone J.P. Crosstalk between the thyroid hormone and peroxisome proliferator-activated receptors in regulating peroxisome proliferator-responsive genes. Mol. Cell. Endocrinol. 116 (1996) 213-221
62. Hvattum E., Grav H.J., and Bremer J. Hormonal and substrate regulation of 3-thia fatty acid metabolism in Morris 7800C1 hepatoma cells. Biochem. J. 294 (1993) 917-921
63. Issemann I., and Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347 (1990) 645-650
64. Issemann I., Prince R.A., Tugwood J.D., and Green S. A role for fatty acids and liver fatty acid binding protein in peroxisome proliferation?. Biochem. Soc. Trans. 20 (1992) 824-827
65. Issemann I., Prince R.A., Tugwood J.D., and Green S. The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J. Mol. Endocrinol. 11 (1993) 37-47
66. Janknecht R., and Hunter T. Transcription-A growing coactivator network. Nature (London 383 (1996) 22-23
67. Jedlitschky G., Huber M., Volkl A., Muller M., Leier I., Muller J., Lehmann W.D., Fahimi H.D., and Keppler D. Peroxisomal degradation of leukotriene by beta-oxidation from the omega-end. J. Biol. Chem. 266 (1991) 24763-24772
68. Jow L., and Mukherjee R. The human peroxisome proliferator-activated receptor (PPAR) subtype NUCI represses the activation of hPPARα thyroid hormone receptors. J. Biol. Chem. 270 (1995) 3836-3840
69. Juge-Aubry C.E., Gorla-Bajszczak A., Pernin A., Lemberger T., Wahli W., Burger A.G., and Meier C.A. Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. J. Biol. Chem. 270 (1995) 18117-18122
70. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., Lin S.C., Heyman R.A., Rose D.W., Glass C.K., and Rosenfeld M.G. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85 (1996) 403-414
71. Keller H., Mahfoudi A., Dreyer C., Hihi A.K., Medin J., Ozato K., and Wahli W. Peroxisome proliferator-activated receptors and lipid metabolism. Ann. N.Y. Acad. Sci. 684 (1993) 157-173
72. Keller H., Dreyer C., Medin J., Mahfoudi A., Ozato K., and Wahli W. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc. Natl. Acad. Sci. USA 90 (1993) 2160-2164
73. Keller H., Givel F., Perroud M., and Wahli W. Signaling cross-talk between peroxisome proliferator-activated receptor/retinoid X receptor and estrogen receptor through estrogen response elements. Mol. Endocrinol. 9 (1995) 794-804
74. Kim J.B., and Spiegelman B.M. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev. 10 (1996) 1096-1107
75. Klein-Hitpass L., Tsai S.Y., Weigel N.L., Allan G.F., Riley D., Rodriguez R., Schrader W.T., Tsai M.-J., and O'Malley B.W. The progesterone receptor stimulate cell-free transcription by enhancing the formation of a stable preinitiation complex. Cell 60 (1990) 247-257
76. Kliewer S.A., Umesono K., Noonan D.J., Heyman R.A., and Evans R.M. Convergence of 9-cis retinoic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors. Nature (London 358 (1992) 771-774
77. Kliewer S.A., Umesono K., Heyman R.A., Mangelsdorf D.J., Dyck J.A., and Evans R.M. Retinoid X receptor-COUP-TF interactions modulate retinoic acid signaling. Proc. Natl. Acad. Sci. USA 89 (1992) 1448-1452
78. Kliewer S.A., Forman B.M., Blumberg B., Ong E.S., Borgmeyer U., Mangelsdorf D.J., Umesono K., and Evans R.M. Differential expression and activation of a murine peroxisomal proliferator-activated receptors. Proc. Natl. Acad. Sci. USA 91 (1994) 7355-7359
79. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 833 (1995) 813-819
80. Krey G., Keller H., Mahfoudi A., Medin J., Ozato K., Dreyer C., and Wahli W. Xenopus peroxisome proliferator activated receptors: Genomic organization, response element recognition, heterodimer formation with retinoid X receptor and activation by fatty acids. J. Steroid Biochem. Mol. Biol. 47 (1993) 65-73
81. Krey G., Mahfoudi A., and Wahli W. Functional interactions of peroxisome proliferator-activated receptor, retinoid-X receptor, and Sp1 in the transcriptional regulation of the acyl-Coenzyme-A oxidase promoter. Mol. Endocrinol. 9 (1995) 219-231
82. Kurokawa R., Söderström M., Hörlein A., Halachmi S., Brown M., Rosenfeld M.G., and Glass C.K. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature (London 377 (1995) 451-454
83. Ladias J.A., Hadzopoulou-Cladaras M., Kardassis D., Cardot P., Cheng J., Zannis V., and Cladaras C. Transcriptional regulation of human apolipoprotein genes ApoB, ApoCIII, and ApoAII by members of the steroid hormone receptor superfamily HNF-4, ARP-11, EAR-2, and EAR-3. J. Biol. Chem. 267 (1992) 15849-15860
84. Lalwani N.D., Fahl W.E., and Reddy J.K. Detection of a nafenopin-binding in rat liver cytosol associated with the induction of peroxisome proliferation by hypolipidemic compounds. Biochim. Biophys. Res. Commun. 116 (1983) 388-393
85. Lalwani N.D., Alvares K., Reddy M.K., Reddy M.N., and Parikh I. Peroxisome proliferator-binding protein: Identification and partial characterization of nafenopin, clofibric binding and ciprofibrate-binding protein from rat liver. Proc. Natl. Acad. Sci. USA 84 (1987) 5342-5346
86. Lambe K.G., and Tugwood J.D. A human peroxisome-proliferator-activated receptor-γ is activated by inducers of adipogenesis, including thiazolidinedione drugs. Eur. J. Biochem. 239 (1996) 1-7
87. Laudet V., Hanni C., Coll J., Catzeflis F., and Stehelin D. Evolution of the nuclear receptor gene superfamily. EMBO J. 11 (1992) 1003-1013
88. Lazarow P.B., and deDuve C. A fatty acyl-CoA oxidizing system in rat liver peroxisome, enhancement by clofibrate, a hypolipidemic drug. Proc. Natl. Acad. Sci. USA 73 (1976) 2043-2046
89. Le Douarin B., Zechel C., Garnier J.M., Lutz Y., Tora L., Pierrat P., Heery D., Gronemeyer H., Chambon P., and Losson R. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J. 14 (1995) 2020-2033
90. Le Douarin B., Nielsen A.L., Garnier J.M., Ichinose H., Jeanmougin F., Losson R., and Chambon P. A possible involvement of TIF1-alpha and TIF1-beta in the epigenetic control of transcription by nuclear receptors. EMBO J. 15 (1996) 6701-6715
91. Lee J.W., Ryan F., Swaffield J.C., Johnston S.A., and Moore D.D. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature (London 374 (1995) 91-94
92. Lee S.-T., Pineau T., Drago J., Lee E.J., Owens J.W., Kroetz D.L., Fernandez-Salguero M., Westphal H., and Gonzales F. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15 (1995) 3012-3022
93. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Wilson T.M., and Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ. J. Biol. Chem. 270 (1995) 12953-12956
94. Lehmann J.M., Lenhard J.M., Oliver B.B., Ringold G.M., and Kliewer S.A. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 272 (1997) 3406-3410
95. Lemberger T., Saladin R., Vazquez M., Assimacopoulos F., Staels B., Desvergne B., Wahli W., and Auwerx J. Expression of the peroxisome proliferator-activated receptor α gene is stimulated by stress and follows a diurnal rhythm. J. Biol. Chem. 271 (1996) 1764-1769
96. L'Horset F., Dauvois S., Heery D.M., Cavailles V., and Parker M.G. RIP140 interacts with multiple nuclear receptors by means of two distinct sites. Mol. Cell. Biol. 16 11 (1996) 6029-6036
97. Lock E.A., Mitchell A.M., and Elcombe C.R. Biochemical mechanisms of induction of hepatic peroxisome proliferation. Annu. Rev. Pharmacol. Toxicol. 29 (1989) 145-163
98. Mangelsdorf D.J., and Evans R.M. The RXR heterodimers and orphan receptors. Cell 83 (1995) 941 850
99. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schütz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., and Evans R.M. The nuclear receptor superfamily: The second decade. Cell 83 (1995) 835-839
100. Marcus S.L., Miyata K.S., Zhang B., Subramani S., Rachubinski R.A., and Capone J.P. Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferator-responsive elements of the rat hydratase/dehydrogenase and fatty acyl-CoA oxidase genes but differentially induce expression. Proc. Natl. Acad. Sci. USA 90 (1993) 5723-5727
101. Marshall W.S., Goodson T., Cullinan G.J., Swanson-Bean D., Haisch K.D., Rinkema L.E., and Fleisch J.H. Leukotriene receptor antagonists. I. Synthesis and structure-activity relationships of alkoxyacetophenone derivatives. J. Med. Chem. 30 (1987) 682-689
102. McEwan I.J., Wright A.P.H., and Gustafsson J.A. Mechanism of gene expression by the glucocorticoid receptor-Role of protein-protein interactions. BioEssays 19 (1997) 153-160
103. McEwen B.S., and Sapolsky R.M. Stress and cognitive function. Curr. Opin. Neurobiol. 5 (1995) 205-216
104. Miyata K.S., Zhang B., Marcus S.L., Capone J.P., and Rachubinski R.A. Chicken ovalbumin upstream promoter transcription factor (COUP-TF) binds to a peroxisome proliferator-response element and antagonizes peroxisome proliferator-mediated signaling. J. Biol. Chem. 268 (1993) 19169-19172
105. Miyata K.S., McCaw S.E., Marcus S.L., Rachubinski R.A., and Capone J.P. The peroxisome proliferator-activated receptor interacts with the retinoid X receptor in vivo. Gene 148 (1994) 327-330
106. Miyata K.S., McCaw S.E., Patel H.V., Rachubinski R.A., and Capone J.P. The orphan nuclear hormone receptor LXRα interacts with the peroxisome proliferator-activated receptor and inhibits peroxisome proliferator signaling. J. Biol. Chem. 271 (1996) 9189-9192
107. Muerhoff A.S., Griffin K.J., and Johnson E.F. The peroxisome proliferator activated receptor mediates the induction of CYP 4A6, a cytochrome P450 fatty acid ω-hydroxylase, by clofibric acid. J. Biol. Chem. 267 (1992) 19051-19053
108. Mukherjee R., Jow L., Noonan D., and McDonnel D.P. Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators. J. Steroid Biochem. Mol. Biol. 51 (1994) 157-166
109. Naar A.M., Boutin J.-M., Lipkin S.M., Yu V.C., Holloway J.M., Glass D.K., and Rosenfeld M.G. The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to other three nuclear receptors. Cell 65 (1991) 1267-1279
110. Ogryzko V.V., Schultz R.L., Russanova V., Howard B.H., and Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87 (1996) 953-959
111. Onate S.A., Tsai S.Y., Tsai M.J., and O'Malley B.W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270 (1995) 1354-1357
112. Palmer C.N.A., Hsu M.-H.A., Muerhoff S., Griffin K.J., and Johnson E.F. Interaction of the peroxisome proliferator-activated receptor α with the retinoid X receptor α unmasks a cryptic peroxisome proliferator response element that overlaps an ARP-1 binding site in the CYP 4A6 promoter. J. Biol. Chem. 269 (1994) 18083-18089
113. Rao S.M., and Reddy J.K. Peroxisome proliferation and hepatocarcinogenesis. Carcinogenesis 8 (1987) 631-636
114. Reddy J.K., and Lalwani N.D. Carcinogenesis by hepatic peroxisome proliferators: Evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. Crit. Rev. Toxicol. 12 (1983) 1-58
115. Reddy J.K., and Rao S.M. Peroxisome proliferators and cancer-Mechanisms and implications. TIPS 7 (1986) 438-443
116. Rodriguez J.C., Gil-Gomez G., Hegardt F.G., and Haro D. Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methyl-glutaryl-CoA synthetase gene by fatty acids. J. Biol. Chem. 269 (1994) 18767-18772
117. Samuelsson B., Dahlen S.-E., Lindgren J.A., Rouzer C.A., and Serhan C.N. Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects. Science 237 (1987) 1171-1176
118. Sande S., and Privalsky M.L. Identification of TRACs (T-3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors. Mol. Endocrinol. 10 (1996) 813-825
119. Schmidt A., Endo N., Rutledge S.J., Vogel R., Shinar D., and Rodan G.A. Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol. Endocrinol. 6 (1992) 1634-1641
120. Schoonjans K., Watanabe M., Suzuki H., Mahfoudi A., Krey G., Wahli W., Grimaldi P., Staels B., Yamamoto T., and Auwerx J. Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter. J. Biol. Chem. 270 (1995) 19269-19276
121. Schoonjans K., Staels B., and Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res. 37 (1996) 907-925
122. Schoonjans K., Staels B., and Auwerx J. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta 1302 (1996) 93-109
123. Seol W., Mahon M.J., Lee Y.K., and Moore D.D. Two receptor interacting domains in the nuclear hormone receptor corepressor rip13/n-cor. Mol. Endocrinol. 10 (1996) 1646-1655
124. Sher T., Yi H.-F., McBride W., and Gonzales F. cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry 32 (1993) 5598-5604
125. Sørensen H.N., Gautvik K.M., Bremer J., and Spydevold Ø. Induction of the three peroxisomal beta-oxidation enzymes is synergistically regulated by dexamethasone and fatty acid, and counteracted by insulin in Morris 7800C1 hepatoma cells in culture. Eur. J. Biochem. 208 (1992) 705-711
126. Sørensen H.N., Hvattum E., Paulssen E.J., Gautvik K.M., Bremer J., and Spydevold Ø. Induction of peroxisomal acyl-CoA oxidase by 3-thia fatty acid in hepatoma cells and hepatocytes in culture is modified by dexamethasone and insulin. Biochim. Biophys. Acta 1171 (1993) 263-271
127. Sörensen, H. N., Steineger, H. H., Eskild, W., Crickmore, A., Risan, K. A., Spydevold, Ø, Gautvik, K. M., and Gustafsson, J.-Å. (1997). Manuscript in preparation.
128. Staels B., Vu-Dac N., Kosykh V., Saladin R., Fruchart J.-C., Dallongeville J., and Auwerx J. Fibrates down-regulate apolipoprotein C-III expression independent of induction of peroxisomal acyl-CoA A oxidase. J. Clin. Invest. 95 (1995) 705-712
129. Steineger H.H., Sørensen H.N., Tugwood J.D., Skrede S., Spydevold Ø., and Gautvik K.M. Dexamethasone and insulin demonstrate marked and opposite regulation of the steady-state mRNA level of the peroxisomal proliferator-activated receptor (PPAR) in hepatic cells. Eur. J. Biochem. 225 (1994) 967-974
130. Stunnenberg H.G. Mechanisms of transactivation by retinoic acid receptors. BioEssays 15 (1993) 309-315
131. Tontonoz P., Hu E., Graves R., Budavari A.I., and Spiegelman B.M. mP-PARγ2: Tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8 (1994) 1224-1234
132. Tontonoz P., Graves R.A., Budavari A.I., Erdjument-Bromage H., Lui M., Tempst P., and Spiegelman B.M. Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPARγ and RXRα. Nucleic Acids Res. 22 (1994) 5628-5634
133. Tontonoz P., Hu E., and Spiegelman B.M. Stimulation of adipogenesis in fibroblasts by PPARγ, a lipid-activated transcription factor. Cell 79 (1994) 1147-1234
134. Tontonoz P., Hu E., and Spiegelman B.M. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. Curr. Opin. Genet. Dev. 5 (1995) 571-576
135. Tontonoz P., Hu E., Devine J., Beale E.G., and Spiegelman B.M. PPARγ2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol. Cell. Biol. 15 (1995) 351-357
136. Treuter, E., Albrektsen, T., Johansson, L., Leers, J., and Gustafsson, J.-Å. (1997). Identification and functional properties of nuclear factor RIP140 as a cofactor for the peroxisome proliferator-activated receptor (PPAR). Submitted for publication.
137. Tsai S.Y., Srinivasan G., Allan G.F., Thompson E.B., O'Malley B.W., and Tsai M.-J. Recombinant human glucocorticoid receptor induces transcription of hormone response genes in vitro. J. Biol. Chem. 265 (1990) 17055-17061
138. Tugwood J.D., Issemann I., Anderson R.G., Bundell K.R., McPheat W.L., and Green S. The mouse peroxisome proliferator activated receptor recognize a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 11 (1992) 433-439
139. Umesono K., Murakami K.K., Thompson C.C., and Evans R.M. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 65 (1991) 1255-1266
140. Voegel J.J., Heine M.J., Zechel C., Chambon P., and Gronemeyer H. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15 (1996) 3667-3675
141. vom Baur E., Zechel C., Heery D., Heine M.J., Garnier J.M., Vivat V., Le Douarin B., Gronemeyer H., Chambon P., and Losson R. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J. 15 (1996) 110-124
142. von Schacky C., Kiefi R., Marcus A.J., Breokman M.J., and Kaminski W.E. Dietary n-3 fatty acids accelerate catabolism of leukotriene B4 in human granulocytes. Biochim. Biophys. Acta 1166 (1993) 20-24
143. Vu-Dac N., Schoonjans K., Laine B., Fruchart J.-C., Auwerx J., and Staels B. Negative regulation of the human apolipiprotein A-I promoter by fibrates can be attenuated by the interaction of PPAR with its response element. J. Biol. Chem. 269 (1994) 31012-31018
144. Vu-Dac N., Schoonjans K., Kosykh V., Dallongeville J., Fruchart J.-C., Staels B., and Auwerx J. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. J. Clin. Invest. 96 (1995) 741-750
145. Widom R.L., Rhee M., and Karathanasis S.K. Repression by ARP-1 sensitizes apolipoprotein AI gene responsiveness to RXR alpha and retinoic acid. Mol. Cell. Biol. 2 (1992) 3380-3389
146. Winrow C.J., Marcus S.L., Miyata K.S., Zhang B., Capone J.P., and Rachubinski R.A. Transactivation of the peroxisome proliferator-activated receptor is differentially modulated by hepatocyte nuclear factor-4. Gene Expression 4 (1994) 53-62
147. Winrow C.J., Miyata K.S., Marcus S.L., Burns K., Michalak M., Capone J.P., and Rachubinski R.A. Calreticulin modulates the in vitro DNA binding but not the in vivo transcriptional activation by peroxisome proliferator-activated receptor/retinoid X receptor heterodimers. Mol. Cell. Endocrinol. 111 (1995) 175-179
148. Wu P., Skrede S., Hvattum E., and Bremer J. Substrate and hormonal regulation of palmitoyl-CoA synthetase in 7800C1 Morris hepatoma cells and cultured rat hepatocytes. Biochim. Biophys. Acta 1170 (1993) 118-124
149. Wu Z., Xie Y., Bucher N., and Farmer S.R. Conditional ectopic expression of C/EBPβ in NIH-3T3 cells induces PPARγ and stimulates adipogenesis. Genes Dev. 9 (1995) 2350-2363
150. Wurtz J.M., Bourguet W., Renaud J.P., Vivat V., Chambon P., Moras D., and Gronemeyer H. A canonical structure for the ligand-binding domain of nuclear receptors [see comments; published erratum appears in. Nat. Struct. Biol. 3 2 (1996) 206
151. Nat. Struct. Biol. 3 (1996) 87-94
152. Xing G., Zhang L., Heynen T., Yoshikawa T., Smith M., Weiss S., and Detera Wadleigh S. Rat PPARδ contains a CGG triplet repeat and is prominently expressed in the thalamic nuclei. Biochim. Biophys. Res. Commun. 217 (1995) 1015-1025
153. Yamada J., Sugiyama H., Watanabe T., and Suga T. Suppressive effect of growth hormone on the expression of peroxisome proliferator-activated receptor in cultured rat hepatocytes. Res. Commun. Mol. Pathol. Pharmacol. 90 (1995) 173-176
154. Yao T.P., Ku G., Zhou N., Scully R., and Livingston D.M. The nuclear hormone receptor coactivator SRC-1 is a specific taget of p300. Proc. Natl. Acad. Sci. USA 93 (1996) 10626-10631
155. Yeh S., and Chang C. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc. Natl. Acad. Sci. USA 93 (1996) 5517-5521
156. Yeh W.C., Cao Z., Classon M., and McKnight S.L. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev. 9 (1995) 168-181
157. Yu K., Bayona W., Kallen C.B., Harding H.P., Ravera C., McMahon G., Brown M., and Lazar M.A. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem. 270 (1995) 23975-23983
158. Zammit V.A. Role of insulin in hepatic fatty acid partitioning: Emerging concepts. Biochem. J. 314 (1996) 1-14
159. Zhang B., Marcus S.L., Sajjadi F.G., Alvares K., Reddy J.K., Subramani S., Rachubinski R.A., and Capone J.P. Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase. Proc. Natl. Acad. Sci. USA 89 (1992) 7541-7545
160. Zhang B., Berger J., Zhou G.C., Elbrecht A., Biswas S., White-Carrington S., Szalkowski D., and Moller D.E. Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 271 (1996) 31771-31774
161. Zhang B., Berger J., Hu E., Szalkowski D., White-Carrington S., Spiegelman B.M., and Moller D.E. Negative regulation of peroxisome proliferator-activated receptor-γ gene expression contributes to the adipogenic effects of tumor necrosis factor-α. Mol. Endocrinol. 10 (1996) 1457-1466
162. Zhang X., Jeyakumar M., and Bagchi M.K. Ligand-dependent cross-talk between steroid and thyroid hormone receptors. J. Biol. Chem. 271 (1996) 14825-14833
163. Zhu Y., Alvares K., Huang Q., Rao M.S., and Reddy J.K. Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver. J. Biol. Chem. 268 (1993) 26817-26820
164. Zhu Y., Qi C., Korenberg J.R., Chen X.-N., Noya D., Rao M.S., and Reddy J.K. Structural organization of mouse peroxisome proliferator-activated receptor γ (mP-PAR γ) gene: Alternative promoter use and different splicing yield two mPPARγ isoforms. Proc. Natl. Acad. Sci. USA 92 (1995) 7921-7925